ResMed (RMD) Reports In-Line Q3 EPS, Miss on Revenues
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/31/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $229.94 -9.05%
Financial Fact:
Diluted earnings per share (note 2-j): 0.54
Today's EPS Names:
OPY, BNCC, ZVOI, More
Financial Fact:
Diluted earnings per share (note 2-j): 0.54
Today's EPS Names:
OPY, BNCC, ZVOI, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q3 EPS of $0.71, in-line with the analyst estimate of $0.71. Revenue for the quarter came in at $514.2 million versus the consensus estimate of $519.87 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercose ISI downgrades Reddit, says monetization may not offset traffic weakness
- nVent Electric (NVT) Tops Q3 EPS by 13c ; Offers Guidance
- Oppenheimer Holdings (OPY) Reports Q3 EPS of $1.81
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
